Abstract
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP2D6 gene locus. CYP2D6 genetic variation impacts the metabolism of numerous drugs and, thus, can impact drug efficacy and safety. This GeneFocus provides a comprehensive overview and summary of CYP2D6 genetic variation and describes how the information provided by PharmVar is utilized by the Pharmacogenomics Knowledgebase (PharmGKB) and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Cite
CITATION STYLE
Nofziger, C., Turner, A. J., Sangkuhl, K., Whirl-Carrillo, M., Agúndez, J. A. G., Black, J. L., … Gaedigk, A. (2020, January 1). PharmVar GeneFocus: CYP2D6. Clinical Pharmacology and Therapeutics. Nature Publishing Group. https://doi.org/10.1002/cpt.1643
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
